Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6745379 | 0.77 | GNAO1 (0.34) | — | |
| SCHEMBL3224228 | 0.77 | EPHX2 (0.31) | — | |
| SCHEMBL1524628 | 0.76 | CYP1A2 (0.48) | CYP1A2SIGMAR1GRM2GRM3EPHX1 | |
| SCHEMBL2780949 | 0.75 | CYP1A2 (0.42) | CYP1A2SIGMAR1GRM2GRM3HPGD | |
| SCHEMBL474900 | 0.75 | CYP1A2 (0.42) | CYP1A2SIGMAR1GRM2GRM3HPGD | |
| Biphenyl SCHEMBL9515840 | 0.75 | ALDH1A1 (0.42) | CYP1A2SMN1; SMN2HSD17B10 | |
| SCHEMBL11745469 | 0.75 | CYP1A2 (0.37) | CYP1A2SIGMAR1GRM2GRM3EPHX1 | |
| SCHEMBL14923265 | 0.75 | CYP1A2 (0.42) | CYP1A2SIGMAR1GRM2GRM3HPGD | |
| SCHEMBL4655255 | 0.74 | CYP1A2 (0.38) | CYP1A2SIGMAR1 | |
| SCHEMBL15531375 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20220002633-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| US-20220002632-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| WO-2006074979-A1 | USE OF 2,2-DIMETHYL-3-CYCLOHEXYL-1-PROPANOL AS A PERFUME | SYMRISE GMBH & CO. KG (DE) | 2006-07-20 | — | — | WO | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-12576018-B2 | Active agents for skin and hair care with sensory modifying properties | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-4706780-A2 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | SYMRISE AG (DE) | 2026-03-03 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-2174645-A2 | Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate | Symrise GmbH & Co. KG (DE) | 2010-04-14 | — | — | EP | disclosed |
| EP-2158896-A2 | Materials containing aromas incorporating neopentyl glycol isononanoate | Symrise GmbH & Co. KG (DE) | 2010-03-03 | — | — | EP | disclosed |
| EP-2133102-A1 | Odor reducers | Symrise GmbH & Co. KG (DE) | 2009-12-16 | — | — | EP | disclosed |
| US-20090238787-A1 | ODOUR-REDUCING SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2009-09-24 | — | — | US | disclosed |
| US-20090123392-A1 | FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | disclosed |
| WO-2006074979-A1 | USE OF 2,2-DIMETHYL-3-CYCLOHEXYL-1-PROPANOL AS A PERFUME | SYMRISE GMBH & CO. KG (DE) | 2006-07-20 | — | — | WO | disclosed |
| WO-2006074979-A1 | USE OF 2,2-DIMETHYL-3-CYCLOHEXYL-1-PROPANOL AS A PERFUME | SYMRISE GMBH & CO. KG (DE) | 2006-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | CUTA, HLA-A, OAT | CYP1A2 892/4885SIGMAR1 455/4885GRM2 2029/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | CYP1A2 3018/4885SIGMAR1 818/4885GRM2 1178/4885 |
| US-12576018-B2 | Active agents for skin and hair care with sensory modifying properties | SCD5, SMURF1, SGMS1 | CYP1A2 4677/4885SIGMAR1 724/4885GRM2 2594/4885 |
| US-20090238787-A1 | ODOUR-REDUCING SUBSTANCES | ADH1A, ADH1C, ALDH1A1 | CYP1A2 253/4885SIGMAR1 39/4885GRM2 577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.